Clinical Trial Update: A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDR [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating OC-10X for proliferative diabetic retinopathy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Drugs mentioned

• OC-10X

Snippet

Sponsor: OcuCure Therapeutics, Inc. | Conditions: Proliferative Diabetic Retinopathy (PDR) | Phase 2 | Status: TERMINATED